Dyne Therapeutics Inc.

DYN | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.12

+$0.01 (+0.06%)

At close: Sep 21, 2026, 4:00 PM ET

$17.20

+$0.08 (+0.47%)

Pre-market: Sep 22, 2026, 8:03 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-446.21M	-317.42M	-235.94M	-168.1M	-149.29M	-59.44M
Depreciation & Amortization	2.05M	-1.93M	1.67M	1.68M	1.09M	700K
Stock-Based Compensation	45.85M	45.86M	19.97M	15.18M	17.54M	6.59M
Other Working Capital	-11.65M	-10.54M	3.34M	-4.14M	-4.45M	-3.46M
Other Non-Cash Items	-1.49M	607K	-173K	2.97M	-746K	514K
Deferred Income Tax	n/a	n/a	n/a	n/a	2.59M	12K
Change in Working Capital	-3.4M	-19.49M	26.31M	-5.38M	9.26M	5.11M
Operating Cash Flow	-403.21M	-292.37M	-188.16M	-153.65M	-119.56M	-46.51M
Capital Expenditures	-1.92M	-2.38M	-729K	-3.07M	-3.62M	-1.16M
Cash Acquisitions	n/a	n/a	n/a	34K	8K	n/a
Purchase of Investments	-180.53M	-317.44M	-44.26M	-121.18M	-236.72M	-44.5M
Sales Maturities Of Investments	172.46M	115.71M	128.3M	211.45M	102.45M	n/a
Other Investing Acitivies	-18.76M	35K	n/a	-34K	-8K	n/a
Investing Cash Flow	-28.75M	-204.08M	83.31M	87.2M	-137.89M	-45.66M
Debt Repayment	147.7M	n/a	n/a	n/a	n/a	-64K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	36.84M	1.95M	529K	584K	-420K
Financial Cash Flow	890.31M	809.9M	54.32M	37.39M	157.82M	380.69M
Net Cash Flow	458.35M	313.45M	-50.53M	-29.05M	-99.63M	288.52M
Free Cash Flow	-405.13M	-294.75M	-188.89M	-156.71M	-123.18M	-47.67M
Adj. Free Cash Flow	-450.98M	-340.61M	-208.86M	-171.89M	-140.72M	-54.26M
Maintenance CapEx	-1.92M	-1.93M	-729K	-3.07M	-3.62M	-1.16M
Growth CapEx	n/a	-445K	n/a	n/a	n/a	n/a
Owner Earnings	-405.13M	-294.3M	-188.89M	-156.71M	-123.18M	-47.67M